Viewing nowPosidapa Tablet 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 202204699 · Approved 2022.12.29 · Insurance code 694003970
Treatment for reducing blood sugar in type 2 diabetes and reducing cardiovascular risks in chronic heart failure and kidney disease
This medicine is used in conjunction with dietary and exercise therapy to assist blood sugar control in patients with type 2 diabetes. It can enhance blood sugar control effects, either as monotherapy or in combination with other medications. Additionally, it helps reduce the risk of cardiovascular events in patients with type 2 diabetes who have cardiovascular diseases or risk factors. For patients with chronic heart failure, it is used in combination with other treatments to lower the risk of death and hospitalization due to heart failure. In patients with chronic kidney disease, it is used to slow the decline of kidney function and reduce the risk of cardiovascular and kidney-related mortality. Therefore, this medicine is effectively used in improving major health issues such as diabetes, heart failure, and kidney disease.
The recommended dosage of this medicine is 10 mg once daily for monotherapy and additional combination therapy with insulin or other antihyperglycemic agents. For initial combination therapy, when there is no prior experience of treatment with diabetic medication, the recommended starting dosage with metformin is 5 mg or 10 mg once daily. For chronic heart failure and chronic kidney disease, the dosage is 10 mg once daily. Dosage adjustment may be necessary for patients with renal impairment and hepatic impairment.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There is no relevant data.
This medicine should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis, and to those undergoing dialysis. This medicine contains lactose hydrate, hence it should not be administered to patients with lactose intolerance or specific genetic disorders. Care should be taken when using this medicine in patients with reduced fluid volume or kidney dysfunction, and blood pressure, fluid status, and kidney function should be carefully monitored before and after administration. The blood sugar control effect of this medicine may vary based on kidney function, so it is not recommended for patients with severe kidney impairment. While using this medicine, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur, so symptoms should be closely monitored. Genital infections are particularly more common in women, and if there is a history of infections, the risk of recurrence may be higher, so caution is advised. There is a risk of hypoglycemia, so dosages of insulin or sulfonylureas may need to be adjusted if taken together. This medicine may cause a reduction in fluid volume, leading to hypotension or dehydration, so elderly patients or those taking diuretics should be particularly careful. In severe cases, rare complications such as perineal necrosis may occur, so if symptoms like pain, swelling, or redness appear in the genital area or perineum, medical assistance should be sought immediately. Pregnant or breastfeeding women are advised not to use this medicine, and it should be discontinued if pregnancy is confirmed. The safety and efficacy of this medicine for children has not been established, hence it should not be used in pediatric populations. There is no specific antidote in case of overdose, so appropriate treatment should be conducted according to symptoms, and hospitalization may be required for monitoring and treatment. Generally, it is safe to drive or operate machinery while taking this medicine, but caution should be exercised for hypoglycemic symptoms if used with insulin or sulfonylureas. Lastly, it is important to keep this medicine in its original container and store it out of reach of children.
Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes in the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urination
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia, thirst, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, elevated hematocrit, increased serum creatinine during early treatment, dyslipidemia, weight loss, rash, cold sweat, itching, vasogenic headache, orthostatic hypotension, palpitations, insomnia, tinnitus, dyspepsia, nausea, diarrhea, vomiting, weakness, hunger, vaginal discharge
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperature between 1 to 30 degrees Celsius at room temperature.
Yellow, bi-convex, diamond-shaped film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.